Practical Recommendations for Therapeutic Drug Monitoring of Kinase Inhibitors in Oncology-Reference-Cited by-同舟云学术

Practical Recommendations for Therapeutic Drug Monitoring of Kinase Inhibitors in Oncology

Published:2017-09-07 Issue:5 Volume:102 Page:765-776
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Verheijen Remy B.¹,Yu Huixin¹,Schellens Jan H.M.²³,Beijnen Jos H.¹³,Steeghs Neeltje²,Huitema Alwin D.R.¹⁴

Affiliation:

1. Department of Pharmacy & Pharmacology; The Netherlands Cancer Institute - Antoni van Leeuwenhoek; Amsterdam The Netherlands

2. Department of Medical Oncology and Clinical Pharmacology; The Netherlands Cancer Institute - Antoni van Leeuwenhoek; Amsterdam The Netherlands

3. Department of Pharmaceutical Sciences; Utrecht University; Utrecht The Netherlands

4. Department of Clinical Pharmacy; Utrecht University Medical Center; Utrecht The Netherlands

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference110 articles.

1. Practical guidelines for therapeutic drug monitoring of anticancer tyrosine kinase inhibitors: focus on the pharmacokinetic targets.;Yu;Clin. Pharmacokinet.,2014

2. Food and Drug Administration Center for Drug Evaluation and Research Alectinib Clinical Pharmacology and Biopharmaceutics Review http://www.accessdata.fda.gov/drugsatfda_docs/nda/2015/208434Orig1s000ClinPharmR.pdf 2016

3. Food and Drug Administration Center for Drug Evaluation and Research Ceritinib Clinical Pharmacology and Biopharmaceutics Review http://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/205755Orig1s000ClinPharmR.pdf 2014

4. Committee for Medicinal Products for Human Use (CHMP) European Medicines Agency Ceritinib European Public Assessment report. 44 2015

5. European Medicines Agency Committee for Medicinal Products For Human Use (CHMP) Crizotinib European Public Assessment Report http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/002489/WC500134761.pdf 2012

Cited by 202 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Determination of alectinib and its active metabolite in plasma by pipette-tip solid-phase extraction using porous polydopamine graphene oxide adsorbent coupled with high-performance liquid chromatography-ultraviolet detection;Journal of Chromatography A;2024-01

2. Development of a simultaneous quantification method of imatinib and sunitinib and their main metabolites and its application in patients with gastrointestinal stromal tumor;Biomedical Chromatography;2023-12-28

3. Validation of Liquid Chromatography Coupled with Tandem Mass Spectrometry for the Determination of 12 Tyrosine Kinase Inhibitors (TKIs) and Their Application to Therapeutic Drug Monitoring in Adult and Pediatric Populations;Pharmaceutics;2023-12-19

4. Pharmacology of Tyrosine Kinase Inhibitors;Clinical Journal of the American Society of Nephrology;2023-12-11

5. Antiseizure effect of MEK inhibitor in a child with neurofibromatosis type 1—Developmental and epileptic encephalopathy and optic pathway glioma;Epileptic Disorders;2023-11-29